BiotechTube
Infors

Infors

Bottmingen, Switzerland· Est.
infors-ht.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Infors HT is a well-established, privately-held Swiss company operating in the medical devices and lab equipment sector. It has built a strong reputation over nearly three decades by providing reliable, high-quality bioreactors, incubator shakers, and the eve® software platform for bioprocess control and data integration. The company serves a global customer base in research and industrial bioprocessing, emphasizing continuous improvement, quality (ISO 9001 certified since 1996), and sustainability (ISO 14001 certified since 2015). Its business model is based on selling capital equipment and software, complemented by long-term service and support relationships.

Medical Devices

Technology Platform

Integrated hardware-software platform for bioprocessing, comprising incubator shakers, bench-top/pilot bioreactors, and the eve® web-based bioprocess control and data integration software.

Opportunities

The global growth in biologics, cell/gene therapies, and industrial biotechnology drives demand for reliable cultivation equipment.
The trend towards digitalization and process intensification in biomanufacturing creates a significant opportunity for the integrated eve® software platform to become a central control hub.
Expanding service and upgrade programs can build long-term, recurring revenue streams.

Risk Factors

Demand is tied to the capital expenditure cycles of biopharma and research clients, making it susceptible to economic downturns.
The company faces intense competition from large, diversified life science tools corporations.
It must continuously invest in R&D to keep pace with technological shifts like single-use systems and AI-driven control.

Competitive Landscape

Infors HT competes in the crowded life science equipment market against major players like Thermo Fisher Scientific, Sartorius, Eppendorf, and Merck Millipore, which offer broad portfolios and global scale. It also faces competition from specialized bioreactor companies. Its differentiation lies in its integrated hardware-software approach, strong reputation for durability/service, and focus on the specific needs of microbial and cell culture workflows.

More companies in Switzerland →